We are live on
!
Find out more
RCYC
Richard C. Young & Co Portfolio holdings
AUM
$1.36B
1-Year Est. Return
66.41%
This Fund
S&P 500
This Quarter
Est. Return
+11.08%
1 Year Est. Return
+66.41%
3 Year Est. Return
+137.43%
5 Year Est. Return
+151.84%
10 Year Est. Return
+342.18%
AUM
$1.08B
AUM Growth
+$64.5M
(+6.4%)
Cap. Flow
-$30.3M
Cap. Flow
% of AUM
-2.81%
Top 10 Holdings %
Top 10 Hldgs %
31.38%
Holding
96
New
9
Increased
28
Reduced
50
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$13.5M |
| 2 |
Vertiv
VRT
|
+$11.7M |
| 3 |
Costco
COST
|
+$10.8M |
| 4 |
Sterling Infrastructure
STRL
|
+$8.89M |
| 5 |
IBM
IBM
|
+$1.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold MiniShares Trust
GLDM
|
+$13.7M |
| 2 |
Medtronic
MDT
|
+$12.2M |
| 3 |
Kenvue
KVUE
|
+$10.8M |
| 4 |
Honeywell
HON
|
+$7.38M |
| 5 |
Colgate-Palmolive
CL
|
+$6.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.58% |
| 2 | Industrials | 14.58% |
| 3 | Energy | 9.59% |
| 4 | Consumer Staples | 9% |
| 5 | Communication Services | 8.76% |
Similar funds
ACM
SEP
TA
MC
WTB
VC
LWM
SFM
Richard C. Young & Co's Q3 2025 Portfolio in Review
As of Q3 2025, Richard C. Young & Co held 96 positions worth $1.08B, up 6.4% from $1.01B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Richard C. Young & Co's Q3 2025 filing shows 9 new, 28 increased, 50 reduced and 5 closed positions. Its largest new stake was Eli Lilly: 18,185 shares worth $13.9M. The largest sale was SPDR Gold MiniShares Trust, an estimated $13.7M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Energy.
- Richard C. Young & Co's largest Q3 2025 buy was Eli Lilly: 18,185 shares worth $13.9M.
- Richard C. Young & Co added most to Costco in Q3 2025, an estimated $10.8M increase.
- Richard C. Young & Co's biggest Q3 2025 reduction was SPDR Gold MiniShares Trust, cutting an estimated $13.7M.
- Richard C. Young & Co fully exited Medtronic in Q3 2025, selling an estimated $12.2M.
- Richard C. Young & Co's ten largest holdings make up 31% of its $1.08B portfolio in Q3 2025.
- Richard C. Young & Co opened 9 new positions and closed 5 in Q3 2025.
- Richard C. Young & Co's portfolio value rose 6.4% quarter-over-quarter to $1.08B.
Based on Richard C. Young & Co's 13F filing for Q3 2025, filed 12 Nov 2025.